Synaptotagmin I (Syt I), an evolutionarily conserved integral membrane protein of synaptic vesicles, is now known to regulate Ca 2؉ -dependent neurotransmitter release. Syt I protein should undergo several post-translational modifications before maturation and subsequent functioning on synaptic vesicles (e.g. N-glycosylation and fatty acylation in vertebrate Syt I), because the apparent molecular weight of Syt I on synaptic vesicles (mature form, 65,000) was much higher than the calculated molecular weight (47,400) predicted from the cDNA sequences both in vertebrates and invertebrates. Common post-translational modification(s) of Syt I conserved across phylogeny, however, have never been elucidated. In the present study, I discovered that dithreonine residues (Thr-15 Synaptotagmin (Syt) 1 belongs to a family of C-terminal type (C-type) tandem C2 proteins, which are thought to regulate membrane traffic (reviewed in Refs. [1] [2] [3] [4] . To date, 13 distinct syt genes have been identified in mice, rats, and humans and several genes in invertebrates (3) (4) (5) (6) (7) (8) . All members are composed of an N-terminal single transmembrane domain, a diversified spacer domain with varying length, and two conserved Ca 2ϩ -binding C2 domains (known as the C2A
and C2B domains) in the large cytoplasmic domain. Although the Syt family is distinguished from other C-type tandem C2 protein families (e.g. rabphilin, Doc2, and Slp (synaptotagmin-like protein)) in that it has the single transmembrane domain (9, 10) , an alternatively spliced isoform that lacks the transmembrane domain (e.g. Syt VI⌬TM) has been described in some reports (11, 12) . All Syts show type I membrane topology (N extracellular /C cytoplasmic ) and lack a signal peptide sequence (13) (14) (15) . Syt I, an evolutionarily conserved and well characterized isoform abundant in synaptic vesicles, has been shown to be essential for synaptic vesicle exocytosis and endocytosis in neurons by genetic analysis of syt mutants (16 -24) . Antibody or peptide inhibition experiments have shown that two C2 domains of Syt I have crucial roles in the secretory vesicle trafficking in neurons and in some endocrine cells. (i) The C2A domain regulates the fusion step of secretory vesicle exocytosis (25) (26) (27) (28) (29) (30) (31) (32) . Consistent with this, the kinetics of Ca 2ϩ -dependent phospholipid binding activity of the C2A domain in vitro are compatible with the very fast nature of neurotransmitter release (within 200 s) (33, 34) . (ii) The C2B domain regulates the recycling step of synaptic vesicles, probably by binding to the clathrin assembly protein, AP-2 (35-37). (iii) The C2B domain is also suggested to be involved in the fusion step of synaptic vesicles, probably by Ca 2ϩ -dependent self-clustering via the C2B domain (22, 38 -42) . (iv) The WHXL motif in the ␤-8 strand of the C2B domain of Syt I is involved in the synaptic vesicle docking step by binding to certain plasma membrane receptors (43) . Syt I (or II) is also present at growth cone vesicles and has been shown to be essential for neurite outgrowth of chick dorsal root ganglion neurons and PC12 cells (44, 45) . Furthermore, Syt I is involved in the axolemmal repair process in the squid giant axon and plasmalemmal repair in PC12 cells (46, 47) .
Although the roles of the conserved two C2 domains of Syt I have been well demonstrated both in vitro and in vivo as described above, the functions of other domains (i.e. a short N terminus, a transmembrane domain, and a spacer domain), which are not conserved among the Syt family, have not yet been characterized. Recently, I showed that the unique spacer domain of Syt IV is essential for Golgi localization (48) and proposed that the unique spacer domain of each Syt isoform may be involved in distinct subcellular localization of Syt isoforms in the brain (Syts I, III, IV, VI, and VII) (11, 49 -52) . In contrast, however, roles of the transmembrane domain except for the function in membrane anchoring (5, 15) completely remain unknown. In this study, I report a novel function of the transmembrane domain of Syt I as a protein interaction site. By using the mammalian coexpression system, I show that the transmembrane domain of Syt I is essential for interaction with vesicle-associated membrane protein-2 (VAMP-2; also called synaptobrevin), another synaptic vesicle protein essen-tial for neurotransmitter release (53, 54) (reviewed in Refs. 55 and 56) and that the VAMP-2-Syt I interaction promotes Oglycosylation of Thr-15 and Thr-16 of the mouse Syt I N terminus. Based on our findings, I discuss the possible roles of Syt I-VAMP-2 interaction and O-glycosylation of Syt I in secretory vesicle trafficking.
EXPERIMENTAL PROCEDURES

Materials-Restriction enzymes and recombinant
TaqDNA polymerase were obtained from Toyobo Biochemicals (Osaka, Japan). Horseradish peroxidase (HRP)-conjugated anti-T7 tag antibody and anti-T7 tag antibody-conjugated agarose were from Novagen (Madison, WI). HRPconjugated monoclonal (M2) antibody against FLAG peptide and anti-FLAG M2 affinity gel were obtained from Sigma. Anti-Syt I (SYA148) and anti-VAMP-2 mouse monoclonal antibodies were from StreeGen Biotechnologies Corp. (Victoria, Canada). All other chemicals were commercial products of reagent grade. Solutions were made up in deionized water prepared with an Elix10 Water Purification System and Milli-Q Biocel A10 system (Millipore Corp., Bedford, MA).
Synaptotagmin I Expression Constructs-pEF-T7-Syt I, pEF-FLAGSyt I, pEF-T7-Syt I⌬cyto, pEF-T7-Syt I⌬C2AB, pEF-T7-Syt I⌬C2B, pEF-T7-Syt I⌬spacer, pEF-T7-Syt I⌬N, and pEF-T7-Syt I(CA) were prepared as described previously (11, 13, 39, 57) . cDNAs encoding an internal deletion mutant of Syt I⌬C2A (deletion of amino acids 138 -261 of mouse Syt I) were essentially produced by means of two-step PCR techniques as described previously (58) using the following pairs of mutagenic primers: T7 primer and ⌬C2A upper primer; antisense (5Ј-GCAAGCTTGGGCTCCTCCTTTTCTT-3Ј) (left halves) and ⌬C2A lower primer; sense (5Ј-GCAAGCTTCAGAGTGCTGAGAAAGA-3Ј) and SP6 primer (right halves). The left and right halves were separately amplified by using pGEM-T-T7-Syt I as a template (13) , and the two resulting PCR fragments were digested with HindIII (underlined and italicized above), ligated to each other, and reamplified with T7 and SP6 primers. The purified PCR products obtained above were subcloned into pGEM-T Easy vector (Promega; Madison, WI) as described previously (13) . The cDNA fragments of Syt I⌬C2A mutants with a T7 tag were then excised from the pGEM-T Easy vector by NotI digestion and subcloned into the NotI site of a modified pEF-BOS mammalian expression vector (59, 60) . All constructs were verified by DNA sequencing using the Hitachi SQ-5500 DNA sequencer. Plasmid DNA was prepared using Wizard-mini preps (Promega) or Qiagen (Chatsworth, CA) Maxi prep kits.
Site-directed Mutagenesis-Mutant Syt I molecules carrying a Thrto-Ala substitution at amino acid position 15 (T15A), a T16A substitution, a TA (T15A and T16A) substitution, or a Ser-to-Ala substitution (SA; S3A and S5A) were produced by conventional PCR. The following mutagenic oligonucleotides with BamHI linker (underlined) were used for amplification with pEF-T7-Syt I as a template (13): 5Ј-GGATCCA-TGGTGAGTGCCAGTCGTCCTGAGGCCCTGGCTGCCCCTGTCGC-C-3Ј (T15A primer; sense), 5Ј-GGATCCATGGTGAGTGCCAGTCGTC-CTGAGGCCCTGGCTGCCCCTGTCACCGCT-3Ј (T16A primer; sense), 5Ј-GGATCCATGGTGAGTGCCAGTCGTCCTGAGGCCCTGGCTGCC-CCTGTCGCCGCTGTTGCGACCCTT-3Ј (TA primer; sense), and 5Ј-G-GATCCATGGTGGCGCCGCTCGT-3Ј (SA primer; sense). Mutant Syt I molecules carrying a T26A substitution were produced by two-step PCR using the following pairs of oligonucleotides (58): 5Ј-ACACAACGCCG-CGGAGCCAGCCAG-3Ј (T26A-3Ј primer; sense) and 5Ј-CTGGCTGGC-TCCGCGGCGTTGTGT-3Ј (T26A-5Ј primer; antisense). Purified cDNA fragments were first subcloned into pGEM-T Easy vector and then into the modified pEF-BOS mammalian expression vector as described above.
VAMP-2/Synaptobrevin, Syntaxin IA, and SNAP-25 Expression Constructs-cDNAs encoding the open reading frame of mouse VAMP-2/synaptobrevin, syntaxin IA, and SNAP-25 (synaptosome-associated protein of 25 kDa) were amplified by reverse transcriptase-PCR from mouse cerebellum cDNAs (60) using the following sets of primers designed on the basis of mouse or rat sequences previously reported 
FIG. 2. Interaction of synaptotagmin I with VAMP-2 in COS-7
cells. pEF-T7-Syt I, pEF-Syt I⌬N, or a vector control and pEF-FLAG-VAMP-2 were cotransfected or separately transfected into COS-7 cells. Expressed proteins were solubilized with 1% Triton X-100 and immunoprecipitated in the presence or absence of 500 M Ca 2ϩ by anti-T7 tag antibody-conjugated agarose, followed by immunoblotting as described previously (13, 39, 40) . Co-immunoprecipitated (IP) FLAG-tagged VAMP-2 was first detected by HRP-conjugated anti-FLAG antibody ACCACTTCCCAGCATCTT-3Ј (SNAP-25 stop primer, amino acids 201-206). Purified cDNA fragments were first subcloned into pGEM-T Easy vector and then into the modified pEF-BOS mammalian expression vector as described above (named pEF-T7 (or FLAG)-VAMP-2, pEF-T7 (or FLAG)-syntaxin IA, and pEF-T7 (or FLAG)-SNAP-25) pEF-FLAG-VAMP-2⌬31 and pEF-VAMP-2⌬60 were also produced by PCR as described above using the following sets of primers with appropriate restriction enzyme sites (underlined): 5Ј-GCGGATCCCTG-CAGCAGACCCAGGCCCA-3Ј (⌬31 primer; sense) and 5Ј-GCGGATCC-TCGGAGCTGGATGACCGTGC-3Ј (⌬60 primer; sense). pEF-T7-GST-VAMP-2 was similarly constructed by PCR as described previously (64) .
Cell Culture, Transfections, and Immunoprecipitation-Cotransfection of pEF-T7-Syt constructs and pEF-FLAG-VAMP-2, pEF-FLAG-SNAP-25, and/or pEF-FLAG-syntaxin IA constructs into COS-7 cells (7.5 ϫ 10 5 cells, the day before transfection/10-cm plate) was achieved with LipofectAMINE Plus reagent according to the manufacturer's notes (Invitrogen) (39, 57) . Three days after transfection, COS-7 cells were harvested and homogenized in 1 ml of 50 mM HEPES-KOH, pH 7.2, 250 mM NaCl, 1 mM MgCl 2 , 0.1 mM phenylmethylsulfonyl fluoride, 10 M leupeptin, and 10 M pepstatin A in a glass-Teflon Potter homogenizer with 10 strokes at 900 -1,000 rpm. After solubilization with 1% Triton X-100 at 4°C for 1 h, the supernatants (400 l) were obtained by centrifugation at 15,000 rpm for 10 min. Anti-T7 tag-conjugated agarose (wet volume 10 l) and EGTA (final concentration 2 mM) or Ca 2ϩ (final 500 M) was added to the supernatants followed by incubation at 4°C for 1 h with gentle agitation, after which the beads were washed five times with 1 ml of 20 mM HEPES-KOH, pH 7.2, 100 mM NaCl, 1 mM MgCl 2 , 2 mM EGTA (or 500 M Ca 2ϩ ), 0.2% Triton X-100, and protease inhibitors. Immunoprecipitates were analyzed by 12.5% SDS-polyacrylamide gel electrophoresis (PAGE) followed by immunoblot analysis as described previously (13, 39, 40) . The blots shown in this paper are representative of at least two or three independent experiments.
Glycosidase Treatment-Endoglycosidase H, N-glycosidase F (Roche Diagnostics), and sialidase (neuraminidase; Sigma) treatments were performed as described with slight modifications (14, 48, 65) . Two l of the cell lysates solubilized with 1% Triton X-100 was added to four volumes of the buffer (20 mM HEPES-KOH, pH 7.2, 0.1% SDS, and 0.5% Nonidet P-40). After the addition of 1 milliunit of O-glycosidase (Roche Diagnostics), the mixtures were incubated for 1 h at 37°C. Reactions were stopped by adding SDS sample buffer and boiling for 3 min. Proteins were subjected to 10% SDS-PAGE, followed by immunoblotting with HRP-conjugated anti-T7 tag antibody as described previously (13, 39, 40) .
Direct Interaction between Synaptotagmin I and VAMP-2-The FLAG-Syt I protein in the COS-7 cell lysates was affinity-purified by anti-FLAG M2 Affinity Gel as described previously (66) . The Syt Ibeads (or control beads alone) were incubated for 1 h at 4°C with purified GST-VAMP-2 in 400 l of the binding buffer (50 mM HEPES-KOH, pH 7.2, 150 mM NaCl, 1 mM MgCl 2 , 0.2% Triton X-100). After washing the beads with 1 ml of the binding buffer five times, GST fusion proteins trapped with the beads were analyzed by 10% SDS-PAGE, transferred to a polyvinylidene difluoride membrane (Millipore Corp.), and immunoblotted with HRP-conjugated anti-T7 tag antibody as described previously (13, 39, 40) .
RESULTS
VAMP-2-dependent Post-translational Modification of Synaptotagmin I in COS-7
Cells-In a previous study, I showed that the apparent molecular weight of recombinant mouse synaptotagmin I (or II) expressed in COS-7 cells (immature form; about 55,000) was much smaller than that of endogenous Syt I in the brain or the recombinant Syt I expressed in PC12 cells where Syt I is endogenously expressed abundantly (complete Fig. 1) . The difference in size was partly attributable to the modification of N-linked sugar, because the recombinant Syt I in COS-7 cells was sensitive to endoglycosidase H that cleaves unmodified N-linked sugar and cannot cleave a complex form of N-linked sugar, but the recombinant Syt I in PC12 cells (or brain Syt I) was resistant to such treatment (14, 48) (Fig. 1,  lanes 3 and 6) . By contrast, both proteins were sensitive to endoglycosidase F that cleaves all of the N-linked sugar (48) (Fig. 1, lanes 2 and 5) . Since the molecular mass of the recombinant Syt I in COS-7 cells was significantly smaller than that of the recombinant Syt I in PC12 cells even after N-glycosidase F treatment (compare lanes 2 and 5 in Fig. 1 ), additional modification(s) of Syt I should occur in PC12 cells or in the brain for maturation of the Syt I protein. One possible candidate is fatty acylation of the Cys cluster at the interface between the transmembrane and spacer domains as described previously (57, 67, 68) . However, this is unlikely, because fatty acylation occurred even in the COS-7 cells (57) , and the shift of the molecular mass by fatty acylation on SDS-polyacrylamide gel was very small (see also Fig. 4C, lane 4) (57) .
VAMP-2-dependent O-Glycosylation of
Since in COS-7 cells most of the neuronal proteins that are involved in synaptic vesicle trafficking (e.g. syntaxin IA, SNAP-25, and VAMP-2) are not expressed well (14) , I hypothesized that certain neuronal proteins may help post-translational modification of Syt I in neurons and neuroendocrine cells. To test this hypothesis, I coexpressed T7-tagged Syt I with various neuronal proteins with FLAG tag in COS-7 cells and examined the post-translational modification state of Syt I.
2 Among them, I discovered that coexpression of VAMP-2, another synaptic vesicle protein, with Syt I resulted in the shift of the molecular mass of Syt I to the higher position ( Fig. 2A , open arrowhead in bottom panel) and that VAMP-2 was co-immunoprecipitated with Syt I regardless of the presence of Ca 2ϩ ( Fig.  2A, middle panel) . These effects were not observed when VAMP-2 and Syt I were separately expressed and mixed after solubilization (Fig. 2, Mix) , indicating that the association of VAMP-2-Syt I and the post-translational modification of Syt I should occur in living cells. Interestingly, I could not observe such modification by coexpression of syntaxin IA or SNAP-25, a Syt I-binding protein present at the presynaptic plasma membrane (69 -72) , with Syt I (data not shown). Syt I⅐VAMP-2 complex should be physiologically relevant, because this complex was indeed present in the brain lysate as demonstrated by the co-immunoprecipitation method (73) , and I confirmed this result by using a specific antibody against the Syt I N terminus (data not shown).
VAMP-2-dependent O-Glycosylation of Synaptotagmin I-To determine amino acid(s) that undergo VAMP-2-dependent
post-translational modification of Syt I, I first focused on the Thr or Ser residues in the short N-terminal intravesicular domain, because various cell surface proteins are known to be glycosylated. When the N-terminal 46 amino acids were deleted (Syt I⌬N), VAMP-2-dependent post-translational modification was completely abolished (Fig. 2B, lanes 3 and 4) , al-2 M. Fukuda, unpublished observations.
FIG. 5. Mapping of the domain responsible for VAMP-2 binding in synaptotagmin I.
A, schematic representation of deletion mutants of Syt I. The T7 tag, transmembrane domain (TM), and two C2 domains are represented by hatched, black, and shaded boxes, respectively. Systematic deletions were made from the N or C terminus. The relative VAMP-2-binding activities of each mutant are indicated after the mutant name and were determined on the basis of the results shown in B. Amino acid numbers are given on both sides. B, pEF-T7-Syt I deletion mutants or a vector control and pEF-FLAG-VAMP-2 were cotransfected into COS-7 cells. Expressed proteins were solubilized with 1% Triton X-100 and immunoprecipitated in the presence of 2 mM EGTA by anti-T7 tag antibody-conjugated agarose, followed by immunoblotting as described previously (13, 39, 40) . Co-immunoprecipitated (IP) FLAGtagged VAMP-2 was first detected by HRP-conjugated anti-FLAG antibody (1:10,000 dilution) ( 
VAMP-2-dependent O-Glycosylation of Synaptotagmin I
though VAMP-2 itself can co-immunoprecipitate with Syt I (data not shown). I then performed Ala-based site-directed mutagenesis at the N-terminal intravesicular domain (Fig. 3) . The Syt I(T26A) mutant lacking the N-glycosylation site still exhibited VAMP-2-dependent post-translational modification (Fig. 4A, lanes 9 and 10 in top panel) , indicating that Nglycosylation has no relation to the VAMP-2-dependent modification of Syt I. The Syt I(SA) mutant carrying S3A and S5A substitutions also underwent VAMP-2-dependent modification. In contrast, the Syt I(TA) mutant carrying double substitutions (T15A and T16A) did not exhibit VAMP-2-dependent modification (Fig. 4A, lanes 3 and 4 in top panel) . Since the single substitution (T15A or T16A) could not abrogate the VAMP-2-dependent modification of Syt I, I concluded that both Thr residues are post-translationally modified. To investigate whether Thr-15 and Thr-16 residues are post-translationally modified in brain or PC12 cells, T7-Syt I(TA) was expressed in PC12 cells, where Syt I and VAMP-2 are endogenously expressed. As expected, the apparent molecular mass of T7-Syt I(TA) was much smaller than that of the wild-type protein and was similar in size to the Syt I(T26A) mutant, suggesting that two Thr residues of endogenous Syt I are post-translationally modified (Fig. 4C, lanes 2 and 3) . To further confirm that Thr-15 and Thr-16 residues are indeed glycosylated, Syt I(T26A) mutant protein was treated with either sialidase or O-glycosidase in the presence or absence of VAMP-2 (Fig. 4B) . The Syt I(T26A) mutant in the presence of VAMP-2 was sensitive to sialidase, whereas the Syt I(T26A) mutant in the absence of VAMP-2 was resistant to such treatment. Since the O-glycosidase used in this study cannot cleave modified Olinked sugar, the Syt I(T26A) mutant protein with VAMP-2 was resistant to O-glycosidase treatment. Therefore, I concluded that the Thr-15 and Thr-16 of the mouse Syt I are indeed O-glycosylated, which was further converted to the complex form of oligosaccharides (e.g. the addition of sialic acid).
The Transmembrane Domain of Synaptotagmin I Is Essential for VAMP-2 Binding-Next, I attempted to map the VAMP-2 binding site on Syt I and produced various deletion mutants with a T7 tag (Fig. 5A) . Association of the Syt I deletion mutants with VAMP-2 was evaluated using the mammalian rather than the bacterial expression system, because native Syt I undergoes post-translational modifications such as N-glycosylation (14, 48, 65) and palmitoylation (57, 67, 68) that are responsible for SDS-insensitive Syt oligomerization (57) . When these Syt I deletion mutants were coexpressed with FLAG-VAMP-2, all of the mutants were co-precipitated with FLAG-VAMP-2 (Fig. 5B, middle panel) . Thus, the minimum Amino acid numbers are given on both sides. B, pEF-T7-Syt I or a vector control and pEF-FLAG-VAMP-2 deletion mutants were cotransfected into COS-7 cells. Expressed proteins were solubilized with 1% Triton X-100 and immunoprecipitated in the presence of 2 mM EGTA by anti-T7 tag antibody-conjugated agarose, followed by immunoblotting as described previously (13, 39, 40) . Co-immunoprecipitated (IP) FLAG-tagged VAMP-2 was first detected by HRP-conjugated anti-FLAG antibody (1:10,000 dilution) (middle panel, Blot: anti-FLAG and IP: anti-T7). Then the same blots were stripped and reprobed with HRP-conjugated anti-T7 tag antibody (1:10,000 dilution) to ensure that the same amount of T7-tagged Syt proteins was loaded (bottom panel, Blot: anti-T7 and IP: anti-T7). The upper panel indicates the total expressed FLAG-VAMP-2 ( 1 ⁄40 volume of the reaction mixture) used for immunoprecipitation. Note that deletion of the ␣-helix domain responsible for the SNARE complex assembly (76) 
FIG. 7.
Interaction of synaptotagmin I with isolated VAMP-2 but not SNARE complex. Four plasmids (pEF-T7-Syt I, pEF-FLAG-VAMP-2, pEF-FLAG-SNAP-25, and pEF-FLAG-syntaxin IA) were cotransfected into COS-7 cells. Expressed proteins were solubilized with 1% Triton X-100 and immunoprecipitated in the presence or absence of 500 M Ca 2ϩ by anti-T7 tag antibody-conjugated agarose, followed by immunoblotting as described previously (13, 39, 40) . Co-immunoprecipitated (IP) FLAG-tagged proteins were first detected by HRP-conjugated anti-FLAG antibody 
VAMP-2-dependent O-Glycosylation of Synaptotagmin I
VAMP-2 binding region was found to be the transmembrane domain of Syt I (amino acids 47-81 of mouse Syt I). Interestingly, deletion of the whole cytoplasmic domain (Syt I⌬cyto), two C2 domains (Syt I⌬C2AB), the spacer domain (Syt I⌬spacer), or the C2B domain (Syt I⌬C2B) significantly increased the VAMP-2 binding activity. In contrast, deletion of the C2A domain had no effect on the VAMP-2 binding (Fig. 5B,  middle panel, lane 5) . Since VAMP-2 still interacted with Syt I(CA) mutant (57) , which lacks all of the fatty acylation sites (data not shown), fatty acylation of Syt I is dispensable for VAMP-2 binding to the transmembrane domain of Syt I. Direct interaction of Syt I with VAMP-2 was further demonstrated using purified proteins (Fig. 5C, lane 2 in top panel) . Purified GST-VAMP-2 directly bound Syt I-beads but not beads alone.
To further map the Syt I binding site on VAMP-2, I produced deletion mutants of VAMP-2. VAMP-2 and two plasma membrane proteins (syntaxin I and SNAP-25) form stable heterotrimeric complexes consisting of a four-helix bundle (known as the SNARE (SNAP receptor) complex) (74 -77) , which is thought to be the fundamental machinery for membrane fusion (55, 56, 77) . VAMP-2 consists of a unique N-terminal domain that is not conserved across phylogeny, a conserved helix domain, and a C-terminal transmembrane domain (Fig. 6A) . Deletion of the N-terminal half of the helix domain (⌬60) almost completely abolished Syt I binding activity as well as VAMP-2-dependent modification of Syt I (Fig. 6B, open arrowhead) . In contrast, deletion of the N-terminal 31 amino acids had little effect either on the Syt I binding activity or on the post-translational modification of Syt I (Fig. 6B, lane 3) .
Synaptotagmin I Binds Isolated VAMP-2 but Not SNARE
Complex-Last, I investigated whether Syt I interacts with only the isolated VAMP-2 or heterotrimeric SNARE complex, because the helix domain of VAMP-2 is essential for a stable complex with syntaxin I and SNAP-25 (74 -77) , and recombinant Syt I has been shown to bind isolated syntaxin IA (69) and SNAP-25 (70, 71) . When equimolar amounts of four proteins (T7-Syt I, FLAG-VAMP-2, FLAG-SNAP-25, and FLAG-syntaxin IA) were coexpressed in COS-7 cells and were immunoprecipitated with an anti-T7 tag antibody, VAMP-2 and a small amount of SNAP-25 were co-immunoprecipitated with T7-Syt I, regardless of the presence of 500 M Ca 2ϩ (closed arrow and closed arrowhead, respectively, in Fig. 7, middle panel, lanes 1  and 2) . Such interaction was not due to the nonspecific interactions with agarose beads used for immunoprecipitation, because in the absence of T7-Syt I, none of the SNARE proteins were immunoprecipitated (Fig. 7, middle panel, lanes 3 and 4) . Although equimolar amounts of VAMP-2, SNAP-25, and syntaxin IA were present in the cell lysate, VAMP-2 was preferentially co-immunoprecipitated with Syt I, suggesting that Syt I interacts with isolated VAMP-2 but not the SNARE complex. Under our experimental conditions, I could not observe Syt I⅐syntaxin IA interaction even in the presence of Ca 2ϩ , in contrast to a previous report (69) . This discrepancy may be due to weak interaction between Syt I and syntaxin IA, which would be highly sensitive to extensive washing of the immunoprecipitates.
To rule out the possibility that the three proteins did not form a stable heterotrimeric complex in COS-7 cells although an equimolar amount of proteins was expressed, I examined the presence of the SNARE complex in cell lysates (Fig. 8) . To do so, four proteins (T7-VAMP-2, FLAG-Syt I, FLAG-SNAP-25, and FLAG-syntaxin IA) were co-expressed in COS-7 cells and were immunoprecipitated with anti-T7 tag antibody. As expected, VAMP-2 preferentially interacted with SNAP-25 and Four plasmids (pEF-T7-VAMP-2, pEF-FLAG-Syt I, pEF-FLAG-SNAP-25, and pEF-FLAG-syntaxin IA) were cotransfected into COS-7 cells. Expressed proteins were solubilized with 1% Triton X-100 and immunoprecipitated in the presence or absence of 500 M Ca 2ϩ by anti-T7 tag antibody-conjugated agarose, followed by immunoblotting as described previously (13, 39, 40) . Co-immunoprecipitated (IP) FLAG-tagged proteins were first detected by HRP-conjugated anti-FLAG antibody ( Five Cys residues at the interface between the transmembrane (black box) and spacer domains are fatty acylated (67, 68) , which is crucial for SDS-insensitive oligomerization of Syt I (broken arrow) (57) . Thr-26 of the mouse Syt I is modified by N-linked sugar, which is further converted to the complex form in PC12 cells or the brain (48) . This conversion occurs only in PC12 cells and the brain and not in COS-7 cells; thereby, the Syt I in COS-7 cells is sensitive to endoglycosidase H (Fig. 1) . Additional factor(s) responsible for the conversion of N-linked sugar to the complex form should be missing in COS-7 cells (shaded arrow). Thr-15/Thr-16 of the mouse Syt I are modified by O-linked sugar, which is further converted to the complex form in PC12 cells or the brain (the addition of sialic acid) (Fig. 4) . syntaxin IA to form the SNARE complex (open and closed arrowheads, respectively, in Fig. 8, middle panel) . Surprisingly, only a marginal amount of Syt I was co-immunoprecipitated with VAMP-2 (open arrow in Fig. 8, middle panel) , although most of the Syt I proteins were subjected to the VAMP-2-dependent O-glycosylation (asterisk in Fig. 8, top panel) . Therefore, I concluded that Syt I preferentially interacted with the isolated VAMP-2 but not the VAMP-2 in SNARE complex.
DISCUSSION
Syt I is an evolutionarily conserved synaptic vesicle protein seen from nematodes to humans and is crucial for regulating Ca 2ϩ -dependent neurotransmitter release. The apparent molecular mass of vertebrate and invertebrate Syt I (about 65 kDa, thus also previously called "p65") is always higher than the calculated molecular mass (about 48 kDa) (27, 78) . The difference in molecular mass is thought to result from the post-translational modification of Syt I. Indeed, vertebrate Syt I (or II) contains a single N-glycosylation site (14, 48, 78) and a multiple palmitoylation site (57, 67, 68) . However, since the shift of the molecular mass by fatty acylation was so small on SDS-polyacrylamide gel (Fig. 4C , lane 4) (57) and invertebrate Syt I does not contain an N-glycosylation site, additional modifications (that are possibly common from nematodes to humans) should occur in Syt I. In the present study, I showed that Thr-15 and Thr-16 of the mouse Syt I undergo O-glycosylation (complex form of oligosaccharides) in PC12 cells, but this modification does not occur in COS-7 cells. The most interesting and important finding was that O-glycosylation of Syt I is prompted by co-expression of VAMP-2 with Syt I in COS-7 cells (summarized in Fig. 9 ).
Sequence alignment of the N terminus of Syt I from various species revealed that invertebrate Syt I also contains several di-Thr or di-Ser residues, which are possible O-glycosylation sites (black background in Fig. 3 ). Since the coexpression of squid Syt I (27) with squid VAMP/synaptobrevin in COS-7 cells also promotes the post-translational modification of squid Syt I, 2 VAMP-dependent O-glycosylation of Syt I is most likely to be the common modification of Syt I through evolution. In addition, similar di-Thr/Ser residues at the N-terminal extracellular domain are also found in several other Syt isoforms, suggesting that O-glycosylation might occur in other Syt isoforms. The physiological importance of O-glycosylation of Syt I is currently unknown, but I speculate that O-glycosylation of Syt I may facilitate endocytosis based on the following reports. The Syt I expressed in Chinese hamster ovary cells (probably lacking O-linked sugar) is present at the plasma membrane (79) and it is not endocytosed (80) , whereas the Syt I expressed in PC12 cells (with O-linked sugar) can be endocytosed. Further work is necessary to verify this hypothesis.
Another important finding was that isolated VAMP-2, but not VAMP-2 in the SNARE complex, directly interacts with the transmembrane domain of Syt I. What are the physiological roles of Syt I⅐VAMP-2 interaction in synaptic vesicle trafficking? One possible function is that the interaction with VAMP-2 facilitates sorting of the Syt I protein into synaptic vesicles, since VAMP-2 itself contains a synaptic vesicle-targeting signal (81) and participates in synaptic vesicle formation mediated by the AP3 adaptor complex (82) . This hypothesis is consistent with the previous observation that Syt I expressed in Chinese hamster ovary fibroblasts sorted to the plasma membrane but not to small intracellular vesicles (79) . Additional studies are in progress to determine whether VAMP-2 is involved in sorting of Syt I in neuroendocrine cells. Another possible function is that VAMP-2 tethers Syt I (a possible Ca 2ϩ sensor) just near the fusion machine (SNARE complex; VAMP-2/SNAP-25/syntaxin IA) (55, 56) or that Syt I regulates the availability of VAMP-2 to form the SNARE complex (83) , because Syt I interacts preferentially with isolated VAMP-2 rather than VAMP-2 in the SNARE complex. This hypothesis can also explain why forced overexpression of Syt proteins often causes mislocalization as compared with stable expression at low levels (52, 84, 85) ; the molar ratio of Syt/VAMP-2 exceeds 1. Further work is necessary to determine whether the VAMP-2⅐Syt I complex is involved in sorting of Syt I into synaptic vesicles or exocytosis of synaptic vesicles.
In summary, I showed that di-Thr residues at the intravesicular domain of Syt I undergo VAMP-2-dependent O-glycosylation via direct interaction of VAMP-2 with the transmembrane domain of Syt I in COS-7 cells and that they are indeed modified in PC12 cells. Based on these results, I propose that VAMP-dependent O-glycosylation of Syt I is a conserved mechanism through evolution, which might have important roles in synaptic vesicle trafficking.
